AnalystsRobert DriscollRobert Driscoll's Stock Forecasts
AnalystsRobert Driscoll
Sectors:
Industries:
Analyst Ranking
Bottom 7%
#4069 out of 4337 analysts
Average Return
-11.43%
Win Rate
23%17 out of 73
Risk vs Reward
Poor
Good
Robert Driscoll's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Five Prime Therapeutics IncFPRX | +494.68% | $6.39 | $38.00 | 2020-06-21 - 2021-04-15 | Buy |
Tango Therapeutics IncTNGX | +188.86% | $3.86 | $11.15 | 2023-05-09 - 2023-09-25 | Buy |
Imago Biosciences IncIMGO | +109.97% | $16.95 | $35.59 | 2022-10-27 - 2022-11-21 | Buy |
Sierra Oncology IncSRRA | +102.72% | $58.80 | $119.20 | 2017-02-21 - 2018-02-22 | Buy |
Ideaya Biosciences IncIDYA | +88.58% | $14.18 | $26.74 | 2020-10-06 - 2021-10-05 | Buy |
Robert Driscoll Analyst Color
Get additional color on Robert Driscoll's coverage of popular stocks
Robert Driscoll's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Black Diamond Therapeutics IncBDTX | 4 | Buy | $10.00 | +215.46% | Reiterates | 14 days ago |
Day One Biopharmaceuticals IncDAWN | 4 | Buy | $38.00 | +196.18% | Reiterates | 14 days ago |
Ideaya Biosciences IncIDYA | 3 | Buy | $43.00 | +58.15% | Maintains | 14 days ago |
Alpine Immune Sciences IncALPN | 2 | Buy | $19.00 | +58.60% | Reiterates | a month ago |
Geron CorpGERN | 5 | Buy | $6.00 | +176.50% | Reiterates | a month ago |
Werewolf Therapeutics IncHOWL | 1 | Buy | $9.00 | +345.54% | Initiates Coverage On | a month ago |
Atreca IncBCEL | 4 | Hold | $1.00 | +257.14% | Downgrades | a month ago |
Tyra Biosciences IncTYRA | 2 | Buy | $27.00 | +95.09% | Reiterates | a month ago |
Adicet Bio IncACET | 4 | Buy | $17.00 | +1,114.29% | Reiterates | 2 months ago |
Janux Therapeutics IncJANX | 4 | Buy | $24.00 | +147.17% | Reiterates | 2 months ago |
Zentalis Pharmaceuticals IncZNTL | 6 | Buy | $38.00 | +83.13% | Reiterates | 2 months ago |
Arvinas IncARVN | 2 | Hold | $27.00 | +27.24% | Reiterates | 4 months ago |
Replimune Group IncREPL | 3 | Buy | $52.00 | +221.98% | Reiterates | 4 months ago |
Igm Biosciences IncIGMS | 5 | Buy | $37.00 | +405.46% | Reiterates | 4 months ago |
Elevation Oncology IncELEV | 4 | Buy | $6.00 | +823.08% | Maintains | 4 months ago |
Cyteir Therapeutics IncCYT | 3 | Buy | $3.00 | +7.91% | Reiterates | 4 months ago |
Arcus Biosciences IncRCUS | 1 | Buy | $36.00 | +92.93% | Reiterates | 5 months ago |
Tango Therapeutics IncTNGX | 2 | Buy | $18.00 | +61.43% | Reiterates | 5 months ago |
Foghorn Therapeutics IncFHTX | 3 | Buy | $14.00 | +128.38% | Maintains | 5 months ago |
Surface Oncology IncSURF | 1 | Buy | $3.00 | +180.37% | Reiterates | 7 months ago |
Imago Biosciences IncIMGO | 2 | Hold | $36.00 | -0.03% | Downgrades | 10 months ago |
Aprea Therapeutics IncAPRE | 1 | Buy | $60.00 | N/A | Initiates Coverage On | a year ago |
Cytomx Therapeutics IncCTMX | 3 | Hold | $2.00 | N/A | Downgrades | a year ago |
Harpoon Therapeutics IncHARP | 3 | Buy | $70.00 | N/A | Upgrades | a year ago |
Entasis Therapeutics Holdings IncETTX | 1 | Hold | $1.80 | N/A | Downgrades | 2 years ago |
Compass Therapeutics IncCMPX | 1 | Buy | $8.00 | N/A | Initiates Coverage On | 2 years ago |
Omega Therapeutics IncOMGA | 1 | Buy | $36.00 | N/A | Initiates Coverage On | 2 years ago |
Aceragen IncACGN | 2 | Hold | $1.00 | N/A | Downgrades | 3 years ago |
Five Prime Therapeutics IncFPRX | 4 | Buy | $9.00 | N/A | Upgrades | 3 years ago |
Arbutus Biopharma CorpABUS | 4 | Buy | $4.00 | N/A | Upgrades | 3 years ago |
Kura Oncology IncKURA | 1 | Buy | $28.00 | N/A | Maintains | 3 years ago |
Nabriva Therapeutics PLCNBRVF | 1 | Hold | $250.00 | N/A | Downgrades | 4 years ago |
Paratek Pharmaceuticals IncPRTK | 1 | Buy | $34.00 | N/A | Reiterates | 6 years ago |
Sierra Oncology IncSRRA | 1 | Buy | $4.00 | N/A | Upgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.